300 related articles for article (PubMed ID: 26033493)
21. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
[TBL] [Abstract][Full Text] [Related]
22. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
[TBL] [Abstract][Full Text] [Related]
23. A novel multi-peptide subunit vaccine admixed with AddaVax adjuvant produces significant immunogenicity and protection against Proteus mirabilis urinary tract infection in mice model.
Choubini E; Habibi M; Khorshidi A; Ghasemi A; Asadi Karam MR; Bouzari S
Mol Immunol; 2018 Apr; 96():88-97. PubMed ID: 29525454
[TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization with a recombinant truncated FimH adhesin adjuvanted with CpG oligodeoxynucleotides protects mice against uropathogenic Escherichia coli challenge.
Poggio TV; La Torre JL; Scodeller EA
Can J Microbiol; 2006 Nov; 52(11):1093-102. PubMed ID: 17215901
[TBL] [Abstract][Full Text] [Related]
25. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
[TBL] [Abstract][Full Text] [Related]
26. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.
Savar NS; Jahanian-Najafabadi A; Mahdavi M; Shokrgozar MA; Jafari A; Bouzari S
J Biotechnol; 2014 Apr; 175():31-7. PubMed ID: 24530504
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
[TBL] [Abstract][Full Text] [Related]
28. Effects of the administration of cholera toxin as a mucosal adjuvant on the immune and protective response induced by Proteus mirabilis MrpA fimbrial protein in the urinary tract.
Scavone P; Rial A; Umpierrez A; Chabalgoity A; Zunino P
Microbiol Immunol; 2009 Apr; 53(4):233-40. PubMed ID: 19714860
[TBL] [Abstract][Full Text] [Related]
29. Immunization with recombinant protein Ag43::UpaH with alum and 1,25(OH)2D3 adjuvants significantly protects Balb/C mice against urinary tract infection caused by uropathogenic Escherichia coli.
Habibi M; Azimi S; Khoobbakht D; Roghanian P; Asadi Karam MR
Int Immunopharmacol; 2021 Jul; 96():107638. PubMed ID: 33848909
[TBL] [Abstract][Full Text] [Related]
30. Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo.
Hedayat S; Habibi M; Hosseini Doust R; Asadi Karam MR
Microb Pathog; 2023 Jan; 174():105920. PubMed ID: 36460143
[TBL] [Abstract][Full Text] [Related]
31. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
[TBL] [Abstract][Full Text] [Related]
32. Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract.
Scavone P; Umpiérrez A; Maskell DJ; Zunino P
J Med Microbiol; 2011 Jul; 60(Pt 7):899-904. PubMed ID: 21415205
[TBL] [Abstract][Full Text] [Related]
33. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.
Brumbaugh AR; Smith SN; Mobley HL
Infect Immun; 2013 Sep; 81(9):3309-16. PubMed ID: 23798537
[TBL] [Abstract][Full Text] [Related]
34. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.
Spaulding CN; Klein RD; Ruer S; Kau AL; Schreiber HL; Cusumano ZT; Dodson KW; Pinkner JS; Fremont DH; Janetka JW; Remaut H; Gordon JI; Hultgren SJ
Nature; 2017 Jun; 546(7659):528-532. PubMed ID: 28614296
[TBL] [Abstract][Full Text] [Related]
35. Local induction of bladder Th1 responses to combat urinary tract infections.
Wu J; Bao C; Reinhardt RL; Abraham SN
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653961
[TBL] [Abstract][Full Text] [Related]
36. [Urinary tract infections, immunity, and vaccination].
Luna-Pineda VM; Ochoa S; Cruz-Córdova A; Cázares-Domínguez V; Vélez-González F; Hernández-Castro R; Xicohtencatl-Cortes J
Bol Med Hosp Infant Mex; 2018; 75(2):67-78. PubMed ID: 29658949
[TBL] [Abstract][Full Text] [Related]
37. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
[TBL] [Abstract][Full Text] [Related]
38. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli.
Greene SE; Hibbing ME; Janetka J; Chen SL; Hultgren SJ
mBio; 2015 Jun; 6(4):e00820. PubMed ID: 26126855
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
Fan X; Yue Y; Xiong S
Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
[TBL] [Abstract][Full Text] [Related]
40. In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli.
Hasanzadeh S; Habibi M; Shokrgozar MA; Ahangari Cohan R; Ahmadi K; Asadi Karam MR; Bouzari S
Sci Rep; 2020 Oct; 10(1):16258. PubMed ID: 33004862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
